Medtronic Contegra
This article was originally published in The Gray Sheet
Executive Summary
Pulmonary valved conduit receives FDA Humanitarian Device Exemption approval, firm announces Nov. 24. The bioprosthetic, composed of a bovine jugular vein containing an integral valve that can be used to reconstruct a blood pathway from the right ventricle to the lungs, corrects congenital defects of the right side of the heart in patients under 18. Contegra can be used instead of a human valve, supplies of which are limited, Medtronic notes. The company has been distributing the device outside the U.S. since 1998 and acquired the product from VenPro in 2001...
You may also be interested in...
FDA Assembling Advisors To Discuss Pediatric HDE Products
As part of a periodic review, FDA is bringing together experts to review several products that are conditionally available for pediatric use under the agency's Humanitarian Device Exemption program.
Korean Bioclusters Offer Tax, Other Incentives To Attract Global Firms, Talent
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
CDC Panel Backs Pfizer’s Maternal RSV Vaccine But Leaves Room For AstraZeneca/Sanofi’s Beyfortus
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.